nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0287	0.0344	CcSEcCtD
Cyclobenzaprine—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0275	0.0329	CcSEcCtD
Cyclobenzaprine—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0243	0.029	CcSEcCtD
Cyclobenzaprine—CYP1A2—urine—nephrolithiasis	0.0231	0.221	CbGeAlD
Cyclobenzaprine—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0193	0.0231	CcSEcCtD
Cyclobenzaprine—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0186	0.0223	CcSEcCtD
Cyclobenzaprine—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0182	0.0217	CcSEcCtD
Cyclobenzaprine—HTR2A—urine—nephrolithiasis	0.0181	0.173	CbGeAlD
Cyclobenzaprine—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0179	0.0215	CcSEcCtD
Cyclobenzaprine—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0172	0.0205	CcSEcCtD
Cyclobenzaprine—CYP3A4—urine—nephrolithiasis	0.0167	0.16	CbGeAlD
Cyclobenzaprine—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0167	0.02	CcSEcCtD
Cyclobenzaprine—CYP2D6—urine—nephrolithiasis	0.0165	0.157	CbGeAlD
Cyclobenzaprine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0195	CcSEcCtD
Cyclobenzaprine—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0183	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0166	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0165	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0165	CcSEcCtD
Cyclobenzaprine—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0163	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0157	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0156	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0156	CcSEcCtD
Cyclobenzaprine—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.013	0.0155	CcSEcCtD
Cyclobenzaprine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0153	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0149	CcSEcCtD
Cyclobenzaprine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.012	0.0143	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0142	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0142	CcSEcCtD
Cyclobenzaprine—Cyproheptadine—CHRM3—nephrolithiasis	0.0117	0.197	CrCbGaD
Cyclobenzaprine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0133	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0128	CcSEcCtD
Cyclobenzaprine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0126	CcSEcCtD
Cyclobenzaprine—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0123	CcSEcCtD
Cyclobenzaprine—Tension—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0122	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0122	CcSEcCtD
Cyclobenzaprine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0121	CcSEcCtD
Cyclobenzaprine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00982	0.0117	CcSEcCtD
Cyclobenzaprine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00976	0.0117	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00966	0.0116	CcSEcCtD
Cyclobenzaprine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00957	0.0115	CcSEcCtD
Cyclobenzaprine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00952	0.0114	CcSEcCtD
Cyclobenzaprine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00939	0.0112	CcSEcCtD
Cyclobenzaprine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00936	0.0112	CcSEcCtD
Cyclobenzaprine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00934	0.0112	CcSEcCtD
Cyclobenzaprine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00932	0.0112	CcSEcCtD
Cyclobenzaprine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0092	0.011	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00915	0.011	CcSEcCtD
Cyclobenzaprine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00887	0.0106	CcSEcCtD
Cyclobenzaprine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00887	0.0106	CcSEcCtD
Cyclobenzaprine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00884	0.0106	CcSEcCtD
Cyclobenzaprine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00876	0.0105	CcSEcCtD
Cyclobenzaprine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00867	0.0104	CcSEcCtD
Cyclobenzaprine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00857	0.0103	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0085	0.0102	CcSEcCtD
Cyclobenzaprine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0085	0.0102	CcSEcCtD
Cyclobenzaprine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00836	0.01	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00832	0.00996	CcSEcCtD
Cyclobenzaprine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0083	0.00993	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00822	0.00983	CcSEcCtD
Cyclobenzaprine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0081	0.00969	CcSEcCtD
Cyclobenzaprine—Chlorprothixene—CHRM3—nephrolithiasis	0.00809	0.136	CrCbGaD
Cyclobenzaprine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00794	0.0095	CcSEcCtD
Cyclobenzaprine—Nortriptyline—CHRM3—nephrolithiasis	0.00794	0.134	CrCbGaD
Cyclobenzaprine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00774	0.00927	CcSEcCtD
Cyclobenzaprine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00769	0.0092	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00763	0.00913	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00758	0.00907	CcSEcCtD
Cyclobenzaprine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00756	0.00904	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00748	0.00895	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00739	0.00884	CcSEcCtD
Cyclobenzaprine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00733	0.00877	CcSEcCtD
Cyclobenzaprine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00727	0.0087	CcSEcCtD
Cyclobenzaprine—Promethazine—CHRM3—nephrolithiasis	0.0072	0.121	CrCbGaD
Cyclobenzaprine—Doxepin—CHRM3—nephrolithiasis	0.00713	0.12	CrCbGaD
Cyclobenzaprine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.007	0.00838	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00695	0.00832	CcSEcCtD
Cyclobenzaprine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00675	0.00808	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00672	0.00804	CcSEcCtD
Cyclobenzaprine—Promazine—CHRM3—nephrolithiasis	0.00633	0.107	CrCbGaD
Cyclobenzaprine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00626	0.00749	CcSEcCtD
Cyclobenzaprine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0061	0.0073	CcSEcCtD
Cyclobenzaprine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00601	0.00719	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00582	0.00696	CcSEcCtD
Cyclobenzaprine—CYP1A2—renal system—nephrolithiasis	0.00566	0.054	CbGeAlD
Cyclobenzaprine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00672	CcSEcCtD
Cyclobenzaprine—Imipramine—CHRM3—nephrolithiasis	0.00555	0.0932	CrCbGaD
Cyclobenzaprine—Amitriptyline—CHRM3—nephrolithiasis	0.00551	0.0927	CrCbGaD
Cyclobenzaprine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0054	0.00647	CcSEcCtD
Cyclobenzaprine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00536	0.00641	CcSEcCtD
Cyclobenzaprine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00535	0.00641	CcSEcCtD
Cyclobenzaprine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00532	0.00637	CcSEcCtD
Cyclobenzaprine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00604	CcSEcCtD
Cyclobenzaprine—HTR2A—renal system—nephrolithiasis	0.00442	0.0422	CbGeAlD
Cyclobenzaprine—HTR2A—kidney—nephrolithiasis	0.00428	0.0408	CbGeAlD
Cyclobenzaprine—CYP3A4—renal system—nephrolithiasis	0.00409	0.0391	CbGeAlD
Cyclobenzaprine—CYP2D6—renal system—nephrolithiasis	0.00403	0.0385	CbGeAlD
Cyclobenzaprine—CYP3A4—kidney—nephrolithiasis	0.00396	0.0378	CbGeAlD
Cyclobenzaprine—CYP2D6—kidney—nephrolithiasis	0.00389	0.0372	CbGeAlD
